Gandhi Medicos Logo
Back to health articles
Coronavirus: DGCI approves ‘restricted use’ of anti-HIV Drugs on nCoV Patients

Coronavirus: DGCI approves ‘restricted use’ of anti-HIV Drugs on nCoV Patients

ICMR (Indian Council of Medical Research) had sought an emergency approval from the DCGI (Drug Controller General of India) for the ‘restricted use’ of the combination of 2 medications — lopinavir and ritonavir — for treatment of this respiratory ailment This combination along with other drugs has been used in clinical trials in China, where

Gandhi Medicos March 9, 2020 2 minutes

ICMR (Indian Council of Medical Research) had sought an emergency approval from the DCGI (Drug Controller General of India) for the ‘restricted use’ of the combination of 2 medications — lopinavir and ritonavir — for treatment of this respiratory ailment

This combination along with other drugs has been used in clinical trials in China, where the coronavirus first emerged, and Thailand for treating nCoV-affected patients

The Drug Controller General of India has approved the “restricted use” of a combination of drugs used widely for controlling HIV infection in public health emergency for treating those affected by novel coronavirus (nCoV), official sources said on Wednesday.

The three people from Kerala who contracted coronavirus (Covid-19) recovered without the use of any drugs, and India has adequate supply of the combination of two antiretroviral drugs used to treat HIV and AIDS and are being used to treat Sars-CoV-2, said a scientist at one of the labs run by the Indian Council of Medical Research (ICMR) on the condition of anonymity.

The fixed dose combination of anti-HIV drugs— Lopinavir and Ritonavir — has been used with other drugs in China with varying results, but not in India yet.

The Drug Controller General of India last month approved its restricted use, keeping in view the public health emergency situation that was likely to emerge with cases rising worldwide.

“As an emergency public health measure this can be given to symptomatic patients; about two tablets a day of 400mg dosage for about 14 days is what we advise. It’s a fixed dose combination, which means a single tablet will have both the medicines. It has not been given to anyone so far in India, most patients are on supportive therapy, and stable,” the ICMR scientist added.

“Five patients who required supplemental oxygen also received lopinavir-ritonavir: three experienced a reduction in the need for supplemental oxygen within three days, while two saw their condition worsen. For all patients, the median duration of viral shedding was 12 days,” according to the research.

Source: https://www.hindustantimes.com/india-news/kerala-patients-recovered-without-drugs-expert/story-PwaCRdEXxx9YQyWEMRVvZO.html

Source: https://www.livemint.com/news/india/coronavirus-dgci-approves-restricted-use-of-anti-hiv-drugs-on-ncov-patients-11580912411703.html

This article follows medical accuracy standards and current clinical guidelines.

Important Medical Disclaimer & Legal Notices

Medical Disclaimer: All content found on the Gandhi Medicos Website, including: text, images, audio, or other formats were created for informational purposes only. Offerings for continuing education credits are clearly identified and the appropriate target audience is identified. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this Website.

Gandhi Medicos - Exporters of Generic Medicines. If you think you may have a medical emergency, call your doctor or go to the emergency department, or immediately. Gandhi Medicos does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on Gandhi Medicos. Reliance on any information provided by Gandhi Medicos, Gandhi Medicos employees, contracted writers, or medical professionals presenting content for publication to Gandhi Medicos is solely at your own risk.

The Site may contain health- or medical-related materials or discussions regarding sexually explicit disease states. If you find these materials offensive, you may not want to use our Site. The Site and its Content are provided on an “as is” basis. Gandhi Medicos - Exporters of Generic Medicines. Links to educational content not created by Gandhi Medicos are taken at your own risk. Gandhi Medicos is not responsible for the claims of external websites and education companies.

General Advisory: We advise you to stick to medication routine (or medication adherence), i.e. to take medications as prescribed – the right dose, at the right time, in the right way and frequency. Not taking medicines as prescribed by a doctor or instructed by a pharmacist could lead to disease getting worse, hospitalization, even death.

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Any liability for patent infringement is at the buyer's risk.

All Trademarks, Brands and Service marks that appear on this website belong to their respective owner.